4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0001567619-20-020096
Chief Operating Officer sold 22,770 shares at an average $17.72 ($403,510)
- Chief Operating Officer acquired 6,783 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Anicetti Vincent R · Chief Operating Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-17 | Exercise or conversion : show line 1 in the form | +2,500 | $2.50 | $6,251 | 51,056 | D |
| 2020-11-17 | Sale : show line 2 in the form | −2,500 | $17.50 | $43,744 | 48,556 | D |
| 2020-11-17 | Sale : show line 3 in the form | −12,420 | $17.68 | $219,619 | 36,136 | D |
| 2020-11-17 | Sale : show line 4 in the form | −3,567 | $17.68 | $63,054 | 32,569 | D |
| 2020-11-18 | Exercise or conversion : show line 5 in the form | +4,283 | $12.70 | $54,394 | 36,852 | D |
| 2020-11-18 | Sale : show line 6 in the form | −4,283 | $18.00 | $77,094 | 32,569 | D |
| Open-market sales · 22,770 sh · avg $17.72 · $403,510 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-17 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −2,500 | 7,488 | D |
| 2020-11-18 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −4,283 | 22,500 | D |
Loading xslF345X03/doc1.xml…